The Israeli-based pharmaceutical company Zion Medical broke the news of a successful first clinical trial because it called a potential HIV treatment. Twitter released a new statement. Official results were published and then evaluated as peer-reviewed.
Since the company announced the announcement on October 31, people who want to know more about ”potential treatment fazla are experiencing a wave of excitement in social media.
According to the World Health Organization, at the end of 2017, around 36.9 million people worldwide were living with HIV.
In a statement at the time, Zion Medical explained the results of the first clinical trial of HIV medicine Gammora and said the company had eliminated the treatment by up to 99% of the HI virus within four weeks.
Nine HIV-infected patients, for 10 weeks, Entebbe & # 39; s Dr. Ronald Bata Memorial Hospital, the first and second trial.
But the company has passed tempered expectations, Twitter saying"We would like to thank everyone for their interest in the promising results of our initial clinical trial. We hope that, like you, # Gammora may offer a way to help people affected by HIV to be a convenient way to get rid of infection. Additional trials will help and steps to make #Gammora commercially available.
"We're not there yet, but we're closer, hopeful, and committed to informing you of our progress."
The company also acknowledged that official results should be considered as peer-reviewed in a scientific journal that it hopes to do at the beginning of 2019.
Professor Adrian Puren, Head of the Department of HIV Surveillance and Sero-Molecular Diagnosis of the National Institute of Drug Diseases (NICD), said that Healthcare24 is a long process that needs to be followed before it is brave enough to call the potential for medication. Resort.
"To prove something like this, you have to go through several stages. It is important to do what you need to do research, gather evidence, and find some potentials.
Eniz You have different stages to progress. You may have to do an animal experiment, then a small human experiment – this process is complex, and you may need to do a few tests to start a really small experiment and do a few tests. it determines that the drugs are not toxic and have no harmful side effects.
"You also need to test the effectiveness of the drug at different stages. You are going through the different stages of the trials. At one stage, you also need to eliminate the prejudices from the research and run randomized tests to ensure that people are not really." damaged.
"It is not easy to go through such a thing. It is very complicated, detailed, and quite expensive. the authors know that everything is revised.
"After all the investigations have been carried out and all the regulatory authorities, various ethics committees, and enough scrutiny are examined, then a company can make such a statement. As such, they usually do in large conferences," said Puren.
Ministry of Health, HIV / AIDS, TB and Maternal, Deputy Director General of Child and Women's Health. . As far as we know, there are no published clinical studies on this subject.
"Unless this is published in refereed journals and the World Health Organization does not approve this drug, we cannot take this claim seriously."
On Tuesday, a prominent SA HIV scientist tore the "craze" of "craze", spreading in social media.
“The world of HIV has been working differently for decades, & says Professor Francois Venter of the Institute for Reproductive Health and HIV at the Witwatersrand University, Health says Health-e News.
Saying that the drug is a potential treatment without side effects olduğun is the excessive biological allegations that occur in the public before the official literature Uy. [is published] and should be viewed with deep doubt ".
"I've looked at the press report and the non-company company website and even if you believe their claims, they've been away from testing them for many years," Venter said. Said.
Zion Medical is a relatively new company established in 2014. According to the company website, it develops AIDS and Cancer curing products based on peptides derived from HIV and targeted lentivirus particles.
His partners list the Hebrew University of Jerusalem, Sina Mount Hospital in New York and others as well as the Tel-Aviv Sourasky Medical Center.
Attempts to meet Health24 with Zion Medical completely failed. All forms of e-mails could not be delivered due to an invalid e-mail address and unanswered phone calls.